Duchenne Muscular Dystrophy
The latest news about Duchenne Muscular Dystrophy: headlines, AI summaries and the full story from every source.
- William Blair Initiates Coverage on Solid Biosciences with Outperform Rating
- Sarepta Therapeutics Reports Q3 Earnings Beat on Revenue with Raised 2026 Guidance
- Cumberland Pharmaceuticals Announces NDA Filing Plan for Ifetroban Following Share Price Decline
- Capricor shares rise after new data on deramiocel presented at muscle society congress
- Capricor Shares Drop Sharply Following FDA AdCom Briefing Document Release
- FDA Accepts Dyne Therapeutics' BLA for Duchenne Muscular Dystrophy Treatment
- Dyne Therapeutics Submits Biologics License Application for Duchenne Treatment
- Dyne Therapeutics Announces Launch of Late-Stage Trial for Duchenne Muscular Dystrophy Therapy